付属体の進行段階のアデノカルシノーマの精密腫瘍学:包括的な分子特徴は,行動可能な病変と潜在的な予測バイオマーカーを特定します
Sebastian Lange1,2, Hannah Lisiecki3, Simon Kreutzfeldt4,5
1Department of Internal Medicine II, Klinikum Rechts der Isar, TUM School of Medicine and Health, Technical University of Munich, Munich, Bavaria, Germany.
BMJ open gastroenterology
|August 21, 2025
まとめ
臓腺がんの分子プロファイリングは ほとんどの腫瘍に作用可能な変化を特定し,このまれな癌に対する新しい治療法を提供しました. 精密腫瘍学は,進んだ尾腺がんの治療を導くことができます.
科学分野:
- 腫瘍学
- ゲノミクス
- 精密医療
背景:
- 臓腺がんは稀な悪性腫瘍である.
- 先進的な段階で限られた治療法があります.
研究 の 目的:
- 分子プロファイリングを通して 治療可能な変化を特定する.
- 付属腺がんにおける精密腫瘍学の有用性を評価する.
主な方法:
- 進んだ尾腺がんの19人の患者の遡及分析.
- ドイツの精密腫瘍学プログラム (2015~2021年) のデータを活用した.
- 報告された分子特性,腫瘍委員会の勧告,治療の実施.
主要な成果:
- 腫瘍の95%で潜在的に行動可能な変異 (例えば,ATM,PIK3CA,AKT1変異) が確認された.
- 26% の症例で腫瘍変異負荷が増加した.
- 74%は分子主導の治療勧告を受け,11%は推奨治療を受けた.
結論:
- 分子プロファイリングは 付属腺癌の 操作可能な変異を明らかにします
- 精密腫瘍学的アプローチは この希少な癌に対して有望です
関連する概念動画
Appendicitis-II: Diagnostic Studies and Management
145
Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
145
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


